90Y-hLL2 IgG

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 90Y-hLL2 IgG, covering 2021-08-16 to 2021-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG [Phase 1, Phase 2]